1 |
Wang Y, Liao H, Wang Y, Zhou J, Wang F, Xie Y, Zhao K, Gao W. KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy. BMC Cardiovasc Disord 2021;21:266. [PMID: 34059001 DOI: 10.1186/s12872-021-02053-y] [Reference Citation Analysis]
|
2 |
Li XX, Zhang P, Yang Y, Wang JJ, Zheng YJ, Tan JL, Liu SY, Yan YM, Zhang YY, Cheng YX, Yang HT. Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway. Acta Pharmacol Sin 2022;43:588-601. [PMID: 33967278 DOI: 10.1038/s41401-021-00678-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Cui Y, Hou R, Lv X, Wang F, Yu Z, Cui Y. Identification of Immune-Cell-Related Prognostic Biomarkers of Esophageal Squamous Cell Carcinoma Based on Tumor Microenvironment. Front Oncol 2021;11:771749. [PMID: 34760708 DOI: 10.3389/fonc.2021.771749] [Reference Citation Analysis]
|
4 |
Horvatiček M, Perić M, Bečeheli I, Klasić M, Žutić M, Kesić M, Desoye G, Nakić Radoš S, Ivanišević M, Hranilovic D, Štefulj J. Maternal Metabolic State and Fetal Sex and Genotype Modulate Methylation of the Serotonin Receptor Type 2A Gene (HTR2A) in the Human Placenta. Biomedicines 2022;10:467. [DOI: 10.3390/biomedicines10020467] [Reference Citation Analysis]
|
5 |
Yuan M, Zhao B, Jia H, Zhang C, Zuo X. Sinomenine ameliorates cardiac hypertrophy by activating Nrf2/ARE signaling pathway. Bioengineered 2021;12:12778-88. [PMID: 34895050 DOI: 10.1080/21655979.2021.2000195] [Reference Citation Analysis]
|
6 |
Liao H, Gao W, Ma J, Xue H, Wang Y, Huang D, Yan F, Ye Y. GPR39 promotes cardiac hypertrophy by regulating the AMPK-mTOR pathway and protein synthesis. Cell Biol Int 2021;45:1211-9. [PMID: 33554444 DOI: 10.1002/cbin.11566] [Reference Citation Analysis]
|